MIGUEL ARIZA: Open Payments
NPI 1104850858 · DRACUT, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 18 payments from 9 companies in 2025. Trend: 2023 $88 · 2024 $126 · 2025 $435
Food & beverage: $435
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $118 |
| Amgen Inc. | 3 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $57 |
| Novo Nordisk Inc | 2 | $55 |
| Tandem Diabetes Care, Inc. | 1 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| SANOFI-AVENTIS U.S. LLC | 1 | $26 |
| CeQur Corporation | 1 | $20 |
| Abbott Laboratories | 1 | $18 |
Products named: JARDIANCE, EVENITY, Kerendia, t:slim X2 Insulin Pump with Control-IQ, Rybelsus, TZIELD, Wegovy, CeQur Simplicity.
Industry payments across MA — which companies pay providers there.
